CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Sales	$ 85,587,711	$ 70,354,331
Cost of sales	34,043,435	24,461,575
Gross profit	51,544,276	45,892,756
Operating expenses
Selling expenses	1,227,670	1,950,688
General and administrative expenses	11,328,013	7,853,195
Research and development expenses	1,094,723	1,342,322
Income from operations	37,893,870	34,746,551
Other income (expenses)
Equity in loss of an equity method investee	(216,315)	(95,067)
Interest income	1,751,140	1,376,847
Interest expense	(88,550)	(756,821)
Total other income, net	1,446,275	524,959
Earnings before income tax expense	39,340,145	35,271,510
Income tax expense	6,607,103	5,616,150
Net income	32,733,042	29,655,360
Less: Net income attributable to noncontrolling interest	6,535,787	6,492,888
Net income attributable to China Biologic Products, Inc.	$ 26,197,255	$ 23,162,472
Net income per share of common stock:
Basic	$ 0.96	$ 0.91
Diluted	$ 0.94	$ 0.87
Weighted average shares used in computation:
Basic	26,585,926	24,816,877
Diluted	27,126,838	26,066,786
Net income	$ 32,733,042	$ 29,655,360
Other comprehensive income:
Foreign currency translation adjustment, net of nil income taxes	2,569,752	(854,362)
Comprehensive income	35,302,794	28,800,998
Less: Comprehensive income attributable to noncontrolling interest	6,978,683	6,455,112
Comprehensive income attributable to China Biologic Products, Inc.	$ 28,324,111	$ 22,345,886